Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Takween Advanced Industries Co. Capital/Financing Update 2016

Sep 25, 2016

53261_rns_2016-09-25_08a04c76-3206-4532-aaa9-61d47d48eb93.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

Takween Advanced Industries Co. announces the define right issue subscription period.

1201 · 25/09/2016 15:21:23 · Announcement #43909 · View on Saudi Exchange

Takween Advanced Industries Co. announces the define right issue subscription period.

Takween Advanced Industries Company announces the following details in relation to the subscription period for the new shares and trading of rights, as follows:

First: Rights holders will be able to subscribe during the period from Tuesday 26/12/1437H. (corresponding to 27/09/2016G) until the close of trading on Tuesday 10/01/1438H (corresponding to 11/10/2016G). The subscription will be in two phases:

a) First Subscription Period: Starts on Tuesday 26/12/1437H (corresponding to 27/09/2016G) and continues until the end of the day on Thursday 05/01/1438H (corresponding to 06/10/2016G). During that period, only registered shareholders will be entitled to exercise their rights to subscription (in whole or in part) in the new shares within the limits of the number of rights that have been deposited in their portfolio after the Extraordinary General Assembly held on 20/12/1437H (corresponding to 21/09/2016G). Subscription shall only be approved for a number of new shares based on the number of the rights existing in the portfolio at the end of the trading period. The First Subscription Period shall coincide with the trading period during which Registered shareholders and public may trade their rights.

b) Second Subscription Period: Starts on Sunday 08/01/1438H (corresponding to 09/10/2016G) and continues until the end of the day on Tuesday 10/01/1438H (corresponding to 11/10/2016G). During that period, all holders of rights, whether registered shareholders or persons who purchased rights during the trading period will be allowed to exercise their right to subscribe to the New shares. Trading of rights during this phase is not possible.

If unsubscribed shares remain following the First and Second Subscription Period, the remaining shares will be subscribed to through the Rump Offering as described in the prospectus.

Second: the eligibility ratio is 1.71 rights for each share owned by a registered shareholder in the Company’s share register maintained by Tadawul as at the close of trading on the day of the Extraordinary General Assembly meeting approving the Company’s capital increase.

Third: The offer price is SAR 10 per share.

Fourth: Shareholders, who do not wish to subscribe to the new shares, may sell their allocation of rights during the trading period mentioned above to avoid the decrease in the value of their investment portfolios.

Fifth: To check the daily percentages of the rights price fluctuation after the closing of the rights trading period, please visit Tadawuls at (www.tadawul.com.sa)

Sixth: For information about the share indicative value, please visit the Company’s link on Tadawuls website (www.tadawul.com.sa).

Seventh: For further information about the tradable rights issue mechanism, please visit the following link: (http://www.tadawul.com.sa/static/pages/ar/RI/TR_Booklets.pdf).

Eighth: To check the Company’s rights issue prospectus, please visit the following link: (www.cma.org.sa)

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.